Malin Corporation plc

Irish Stock Exchange MLC.IR

Malin Corporation plc Cash and Short-Term Investments for the year ending December 31, 2023

Malin Corporation plc Cash and Short-Term Investments is NA for the year ending December 31, 2023. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Malin Corporation plc Cash and Short-Term Investments for the year ending December 31, 2021 was USD 37.22 M, a 74.13% change year over year.
Malin Corporation plc Cash and Short-Term Investments for the year ending December 31, 2020 was USD 21.38 M, a -32.45% change year over year.
Malin Corporation plc Cash and Short-Term Investments for the year ending December 31, 2019 was USD 31.65 M, a -43.34% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Irish Stock Exchange: MLC.IR

Malin Corporation plc

CEO	Mr. William F. Daniel
IPO Date	March 25, 2014
Location	Ireland
Headquarters	The Lennox Building
Employees	3
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.

Key trends

Past 5 years